Navigation Links
Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications
Date:6/29/2009

aTyr Pharma Targets for Novel Biotherapeutics Based On Naturally Resected tRNA Synthetases

SAN DIEGO, June 29 /PRNewswire/ -- Pangu BioPharma, a subsidiary of aTyr Pharma in Hong Kong, today announced the filing of its third patent application on proprietary, naturally occurring, resected human tRNA synthetases. Although tRNA synthetases are universal and essential components of protein synthesis machinery found in all organisms, human synthetases have naturally occurring resected variants with potent cell signaling activities that are vital to normal functioning of humans. The work at Pangu BioPharma is focused on identifying and characterizing new examples of the tRNA synthetases resectome. In just the first year of operations, Pangu BioPharma has built a strong patent portfolio that provides fundamental components of aTyr Pharma's portfolio of biotherapeutic candidates that can be used to treat a wide variety of diseases, such as cardiovascular, neurological and metabolic disorders.

Pangu BioPharma is the result of an innovative partnership between aTyr Pharma and the Hong Kong University of Science and Technology (HKUST), with project funding from the Innovation and Technology Commission (ITC) of Hong Kong. James Cai, President of Pangu BioPharma, notes that, "Hong Kong's government and universities are working together to attract exciting drug discovery and development companies to make Hong Kong a new frontier in the biotechnology industry. We based Pangu BioPharma here in Hong Kong in order to capitalize on this unique position in Asia as well as to tap into the highly educated population and support of new technology industries. We are very excited about the productivity and the science being generated by the scientists in our labs here in Hong Kong, and believe that HKUST has been an essential partner in generating this mutual success."

According to Jeff Watkins, CEO of aTyr Pharm
'/>"/>

SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
2. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
3. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
4. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
5. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
6. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
7. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
8. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
9. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
10. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
11. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., SARASOTA, Fla., Nov. 6 /PRNewswire-FirstCall/...nnounced that it has signed a definitive agreement...proprietary medical devices. The Verathon Board o...losing is subject to customary regulatory approval...proval. The parties expect the closing to be comp...
(Date:11/6/2009)..., CHARLESTON, S.C., Nov. 6 /PRNewswire-USNews...be stopping in South Carolina and Georgia througho...order to help uninsured and financially-struggling...ide prescription medicines for free or nearly free...10.2 percent, the Partnership for Prescription Ass...
(Date:11/6/2009)..., PRINCETON, N.J., Nov. 6 /PRNewswire-FirstCall... DSCI), a provider of advanced wound care products...9 results before market on Monday, November 16, 20...ame day to discuss the results at 11:00 am EST. In...tic) or (857) 350-1684 (international), with passc...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Signatec Unveils PX14400 Its High Speed PCI Express Digitizer Capable of Sustained Recordings Over 1 2 GB s with Xilinx Virtex 5 FPGAs for Embedded R 14041 1Signatec Unveils PX14400 Its High Speed PCI Express Digitizer Capable of Sustained Recordings Over 1 2 GB s with Xilinx Virtex 5 FPGAs for Embedded R 14041 2Signatec Unveils PX14400 Its High Speed PCI Express Digitizer Capable of Sustained Recordings Over 1 2 GB s with Xilinx Virtex 5 FPGAs for Embedded R 14041 3Signatec Unveils PX14400 Its High Speed PCI Express Digitizer Capable of Sustained Recordings Over 1 2 GB s with Xilinx Virtex 5 FPGAs for Embedded R 14041 4Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 1Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 2Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 3Clalit Health Services Installs DBSophic 26apos 3Bs Database Performance Optimization Solution 57144 4Innovative New Book Series Encourages Kids to Go Behind Their Parents 26apos 3B Backs and Listen to Experts on Important Health and Wellness Educatio 57141 1Innovative New Book Series Encourages Kids to Go Behind Their Parents 26apos 3B Backs and Listen to Experts on Important Health and Wellness Educatio 57141 2Innovative New Book Series Encourages Kids to Go Behind Their Parents 26apos 3B Backs and Listen to Experts on Important Health and Wellness Educatio 57141 3Innovative New Book Series Encourages Kids to Go Behind Their Parents 26apos 3B Backs and Listen to Experts on Important Health and Wellness Educatio 57141 4Innovative New Book Series Encourages Kids to Go Behind Their Parents 26apos 3B Backs and Listen to Experts on Important Health and Wellness Educatio 57141 5
...stosterone Levels Throughout ...essed Satisfaction with NEBIDO, LEXINGTON, Mass.,...DEV ) today announced that data on NEBIDO(R),(test...ting intramuscular,injection for the treatment of ...entation at the 2008 American Urological Associati...
...day,announced that it has begun patient enrollment...cond PharmacoSurgery(TM) drug product candidate,fo...nts undergoing,unilateral ureteroscopic removal of...n the renal-collecting system or ureter will be en...Surgery(TM) product candidate into clinical,develo...
Other Medicine Technology:Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 2Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 3Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 4Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study 2
(Date:11/7/2009)...IEGO, Nov. 7 The Public Relations Society of Amer...Fellow on Diane Gage Lofgren, senior vice presiden...ser Permanente, tonight at a ceremony at PRSA,s 20...ing inducted into the PRSA College of Fellows is o... said Michael Herman, APR, SAGE, Fellow PRSA, and ...
(Date:11/7/2009)... Forget ‘sweatox’ o...the UK is the usage of the anti-ageing jab ‘...en injected into the décolletage, can reduc...the chest area around the breasts, leaving smoothe... (PRWEB) November 7, 2009 -- Transform, the UK&rs...
(Date:11/6/2009)...ma endorses House health bill loaded with pledge-b...lowing was released today by Americans for Tax Ref...care bill today, President Barack Obama effectivel...ampaign was a lie. ,, During the campaign, Obama ...f taxes on families making less than $250,000 per ...
(Date:11/6/2009)...NGTON, Nov. 6 The U.S. bishops sent an urgent mes... 6, as House members steeped themselves in debate ... care reform bill. ,, Moments before meeting to di... called for "a fair process" that would permit dis...federal law on abortion funding and conscience pro...
(Date:11/6/2009)... A survey released today from J...sicians surveyed (74 percent) feel they have less ...hey did five years ago. , ...ey released today from Jackson Healthcare report...cent) feel they have less control over the way the...
Breaking Medicine News(10 mins):Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3Health News:UK Boobs Get a Boost with 'Breastox' 2Health News:ATR: Obama Lied, His Tax Pledge Died 2Health News:ATR: Obama Lied, His Tax Pledge Died 3Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 3Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 4Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 5Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 2Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 3Health News:Physicians Losing Control of Medicine: New Survey Reports Medical Malpractice as Primary Reason, 4
...ndicated that doctors in the US U.S. doctors often... condition, leaving some patients to suffer for ye... infectious diseases in the world, and according t...t for years, and then can begin multiplying, espec...
...heir first FDA-approved tool to treat drug-resista...e University researcher.// "There are many tr... to combat drug resistance," said Arun Ghosh (pron... the first treatment that is effective against the...
...ggests that women with endometrial cancer should b... to a high risk of several other cancers.// ... 50, of newly diagnosed endometrial cancer patient...rome mutations are at high risk for colon, endomet...
... the risk of suffering a heart attack, according t...l of Medicine.The study is published// in the Augu...nd the full article is available on line at htt...ary heart disease could be at risk for heart attac...
... suppressor gene which was identified by Professor... Experiments done on this gene using the mice mod...o alters the ageing process. Larry Donehower of Ba... and the mice were protected against cancer but ag...
...he trail conducted by National Emphysema Treatment... benefited from surgery// that those who take medi...urgery (LVRS) to treat severe emphysema has result... years, two years longer than the primary results ...
Other Medicine News:Health News:Doctors In US Lack Skills For The Diagnosis Of TB 2Health News:Research Leads to First Treatment for Drug-Resistant HIV 2Health News:Research Leads to First Treatment for Drug-Resistant HIV 3Health News:Research Leads to First Treatment for Drug-Resistant HIV 4Health News:Uterine Cancer May be Clue to Inherited Syndrome 2Health News:Uterine Cancer May be Clue to Inherited Syndrome 3Health News:Risk Of Heart Attack Increased By Gout 2
Burton 2020 Lensmeter
...ing and innovative design, the Burton 7500-I refra... quality and masterful workmanship. At Burton, we ...a truly innovative concept, but to set the industr...ction and stringent testing, we devote more resour...
...et one of two memory positions to automatically re...return button, Durable upholstery, Elegant des... button control panel with three recharging wells,...ic counter-balanced slit lamp arm for easy, smooth...
2.5v Ophthalmic Diagnostic Set
Medicine Products: